Girard Sharp attorneys are investigating claims on behalf of investors who acquired stock in Medical Properties Trust, Inc.
If you acquired Medical Properties Trust, Inc. stock and would like to discuss your potential claim, fill out the form below or call toll-free at (866) 981-4800 for a free consultation with a Girard Sharp attorney.
More About the Medical Properties Trust, Inc. Stockholder Investigation
Medical Properties Trust, Inc. (“MPW”) is a real estate investment trust headquartered in Birmingham, AL focused on the acquisition and development of net-leased healthcare facilities. According to recent reports, MPW “has engaged in billions of dollars of uncommercial transactions with its tenants.” More specifically, the report states that certain of MPW’s tenants “show that they are severely distressed and do not have the ability to meet MPW’s rent requirements if not for financial contributions from MPW”, and that these “round-tripped revenues have no economic substance, and serve for a sole purpose of masking financial distress of MPW’s tenants.”
MPW’s share price declined by approximately 20% between February 21, 2023 and February 27, 2023.
If you acquired Medical Properties Trust stock, speak to an attorney by filling out the form above.
Our Commitment to Excellence
Girard Sharp LLP represents investors, consumers, and institutions in class actions and other complex litigation nationwide. Our class action attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations. We served on the leadership team in the securities litigation following the collapse of Lehman Brothers, the largest bankruptcy in U.S. history, in which total recoveries for investors exceeded $700 million. We also served on the Plaintiffs’ executive committee in the recent spoofing litigation against JPMorgan Chase that returned $60 million to investors. When Sallie Mae, the leading provider of student loans in the United States, misled the public about its financial performance to inflate the company’s stock price, we recovered $35 million for investors in the company. Read more about our track record in securities cases here.
